학술논문
Novel CD123×CD33 bicistronic chimeric antigen receptor (CAR)‐T therapy has potential to reduce escape from single‐target CAR‐T with no more hematotoxicity
Document Type
article
Author
Source
Cancer Communications, Vol 43, Iss 10, Pp 1178-1182 (2023)
Subject
Language
English
ISSN
2523-3548